Clinical Trials
29 trialsProspective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
Wake Forest University Health Sciences
BRE-08
University of Illinois at Chicago
SAFIR02_Breast
UNICANCER
Metronomic Chemotherapy in a Real-world Population of Advanced Breast Cancer Patients
Sun Yat-sen University
COC-IDCB
Shanghai Jiao Tong University School of Medicine
Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer
Indiana University
Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast Cancer
University of California, San Diego
ABCDE
Dana-Farber Cancer Institute
Sunitinib, Cyclophosphamide, and Methotrexate in Treating Patients With Metastatic Breast Cancer
University of California, San Francisco
4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEF
West German Study Group
6MP
University of Oxford
Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast Cancer
Dana-Farber Cancer Institute
TACT2
Institute of Cancer Research, United Kingdom
Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery
University of Washington
Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer
University of Washington
Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer
University of Washington
Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast Cancer
University of Southern California
BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain
OHSU Knight Cancer Institute
ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment
National Cancer Institute, Naples
Dose Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, Fluorouracil) at 14 and 10-11 Day Intervals for Women With Early Stage Breast Cancer
Memorial Sloan Kettering Cancer Center
Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE)
GBG Forschungs GmbH
ICE-II
GBG Forschungs GmbH
Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer
HaEmek Medical Center, Israel
Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast Cancer
Dana-Farber Cancer Institute
ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast Cancer
Dana-Farber Cancer Institute
Bevacizumab With Etoposide and Cisplatin in Breast Cancer Patients With Brain and/or Leptomeningeal Metastasis
National Taiwan University Hospital
Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer
Case Comprehensive Cancer Center
Low Dose Chemotherapy With Aspirin in Patients With Breast Cancer After Neoadjuvant Chemotherapy
University of Vermont
Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer
SCRI Development Innovations, LLC